A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT

被引:0
作者
Jingtao Gao
Mengqiu Gao
Jian Du
Yu Pang
Gary Mao
Nacer Lounis
Nyasha Bakare
Yanxin Jiang
Ying Zhan
Yuhong Liu
Liang Li
机构
[1] Beijing Chest Hospital,Clinical Center On TB
[2] Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute,Department of Tuberculosis
[3] Beijing Chest Hospital,Department of Bacteriology and Immunology
[4] Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute,undefined
[5] Beijing Chest Hospital,undefined
[6] Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute,undefined
[7] Janssen Global Public Health,undefined
[8] Janssen Research & Development,undefined
[9] Janssen Pharmaceutica,undefined
[10] Janssen China Research & Development,undefined
[11] Innovation Alliance On Tuberculosis Diagnosis and Treatment (Beijing) [IATB],undefined
来源
Trials | / 25卷
关键词
Tuberculosis; Bedaquiline; China; Oral Short-course regimen;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 31 条
[31]   INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial [J].
Naidoo, Anushka ;
Dooley, Kelly E. ;
Naidoo, Kogieleum ;
Padayatchi, Nesri ;
Yende-Zuma, Nonhlanhla ;
Perumal, Rubeshan ;
Dorse, Gillian ;
Boodhram, Resha ;
Osuala, Emmanuella Chinonso .
BMJ OPEN, 2022, 12 (11)